Drug-drug interactions in pharmaceutical development /
نام نخستين پديدآور
edited by Albert P. Li.
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Hoboken, N.J. :
نام ناشر، پخش کننده و غيره
Wiley-interscience,
تاریخ نشرو بخش و غیره
2008.
مشخصات ظاهری
نام خاص و کميت اثر
xiv, 244 p., [1] leave of plate :
ساير جزييات
ill. (some col.) ;
ابعاد
25 cm.
فروست
عنوان فروست
Wiley series in drug discovery and development.
یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index.
یادداشتهای مربوط به مندرجات
متن يادداشت
In vitro evaluation of metabolic drug-drug interactions: concepts and practice / Albert P. Li -- In vitro approaches to anticipating clinical drug interactions / Laurie P. Volak, David J. Greenblatt, Lisa L. von Moltke -- Inhibition of drug metabolizing enzymes and drug-drug interactions in drug discovery and development / R. Scott Obach -- Mechanism-based CYP inhibition: enzyme kinetics, assays, and prediction of human drug-drug interactions / Magang Shou -- Genomic approaches to drug-drug interactions / Yi Yang, Jeffrey F. Waring -- Transporters and drug interactions / Yoshihisa Shitara, Toshiharu Horie, and Yuichi Sugiyama -- Transporter-mediated drug interactions: molecular mechanisms and clinical implications / Jiunn H. Lin -- Recent case studies of clinically significant drug-drug interactions and the limits of in vitro prediction methodology / R.H. Levy, I. Ragueneau-Majlessi, C. Collins -- US regulatory perspective: drug-drug interactions / John Strong and Shiew-Mei Huang -- Herbal drug interactions: a Canadian perspective / Brian C. Foster.